Ronald Newbold
Director/Board Member at The University of Virginia Patent Foundation
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Herbert Conrad | M | 91 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | 16 years |
Patricia Russo | F | 71 | 29 years | |
John S. Lazo | M | - |
The University of Virginia Patent Foundation
The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services The University of Virginia Patent Foundation was founded in 1977 and operates as a civic and social association. The private company is based in Charlottesville, VA. | - |
Jennifer West | M | - |
The University of Virginia Patent Foundation
The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services The University of Virginia Patent Foundation was founded in 1977 and operates as a civic and social association. The private company is based in Charlottesville, VA. | - |
John G. MacFarlane | M | - |
The University of Virginia Patent Foundation
The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services The University of Virginia Patent Foundation was founded in 1977 and operates as a civic and social association. The private company is based in Charlottesville, VA. | - |
Elizabeth Crowley | F | 52 | 15 years | |
Peter Grant | M | - |
The University of Virginia Patent Foundation
The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services The University of Virginia Patent Foundation was founded in 1977 and operates as a civic and social association. The private company is based in Charlottesville, VA. | - |
Paul Michel | M | - |
The University of Virginia Patent Foundation
The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services The University of Virginia Patent Foundation was founded in 1977 and operates as a civic and social association. The private company is based in Charlottesville, VA. | - |
Erik L. Hewlett | M | - |
The University of Virginia Patent Foundation
The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services The University of Virginia Patent Foundation was founded in 1977 and operates as a civic and social association. The private company is based in Charlottesville, VA. | - |
Michael J. Lenox | M | - |
The University of Virginia Patent Foundation
The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services The University of Virginia Patent Foundation was founded in 1977 and operates as a civic and social association. The private company is based in Charlottesville, VA. | - |
Melur K. Ramasubramanian | M | - |
The University of Virginia Patent Foundation
The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services The University of Virginia Patent Foundation was founded in 1977 and operates as a civic and social association. The private company is based in Charlottesville, VA. | - |
Kwame Ulmer | M | - |
The University of Virginia Patent Foundation
The University of Virginia Patent Foundation Miscellaneous Commercial ServicesCommercial Services The University of Virginia Patent Foundation was founded in 1977 and operates as a civic and social association. The private company is based in Charlottesville, VA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kenneth Frazier | M | 69 | 30 years | |
P. Vagelos | M | 94 | 19 years | |
Raymond Gilmartin | M | 82 | 2 years | |
George Elston | M | 59 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | 9 years |
William Harrison | M | 80 | - | |
Wendy Yarno | F | 68 | 9 years | |
Donald S. Brooks | M | 88 | - | |
Una Ryan | M | 82 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | 15 years |
Raj Bhikhu Parekh | M | 63 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | - |
David Gionco | M | 63 | 3 years | |
Laura Sepp-Lorenzino | M | 63 | 15 years | |
Taha Keilani | M | 67 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | 4 years |
Anne Tatlock | F | 84 | - | |
Richard Markham | M | 73 | 20 years | |
Larry G. Edwards | M | 52 | 15 years | |
Charles R. Schaller | M | 88 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | 4 years |
Marino Carol | F | - | 8 years | |
Avery Catlin | M | 75 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology AVANT Immunotherapeutics, Inc. is a biopharmaceutical company. Discovers, develops and commercializes vaccines and therapeutics that address various applications including cardiovascular, viral and bacterial diseases. The company markets Rotarix for rotavirus infection and Megan Egg and Megan Vac 1 for Salmonella infection in chicken. It's immunotherapeutic products include TP10 for cardiac bypass surgery and CETi for cholesterol management. The company develops various bacterial vaccines including CholeraGarde for cholera, Ty800 for typhoid fever and Injectable Anthrax for anthrax infection. AVANT Immunotherapeutics has various products in preclinical development stages which include ETEC for Enterotoxigenic E coli infection, Shigella for dysentery, campylobacter for campylobacter infection, Oral Anthrax and Plague vaccines and other food safety and animal health vaccines. AVANT Immunotherapeutics was organized in 1983 and is headquartered in Needham, MA. | 8 years |
Joseph Romanelli | M | 50 | 19 years | |
Elizabeth Hamilton Seabury Wyatt | M | 76 | 20 years | |
Carole A. Sable | M | 62 | 12 years | |
Daniel Bouthillier | M | - | 16 years | |
John W. Wallen | M | 66 | 6 years | |
Thomas Moriarty | M | 60 | - | |
Thomas A. Reed | M | - | 1 years | |
Mark Iwicki | M | 57 | 2 years | |
Kamil Ali-Jackson | F | 65 | 8 years | |
Jim Hinrichs | M | 56 | 5 years | |
Franz Hefti | M | 76 | 7 years | |
Misti Ushio | M | 53 | 10 years | |
Christine Bunt | F | - | 7 years | |
David A. Esposito | M | 55 | 13 years | |
Dorothy P. Bowers | F | - | - | |
François Meurgey | M | - | - | |
Edward Berg | M | - | 8 years | |
Tom Caskey | M | - | 6 years | |
Mark Bach | M | 67 | 17 years | |
Kimberly Murphy | F | 62 | 6 years | |
Ernesto Aycardi | M | 61 | 11 years | |
Hugo Wahnish | M | - | 18 years | |
Desiree Ralls-Morrison | F | 57 | 8 years | |
Benito Munoz | M | 62 | 9 years | |
Berta Strulovici | M | - | - | |
James S. MacDonald | M | - | 17 years | |
Glenn Williams | M | - | 10 years | |
Kevin J. Horgan | M | 64 | 8 years | |
Joe Pedersen | M | - | 23 years | |
Silvana Battaglia | F | 56 | 10 years | |
James Villalobos | M | 55 | - | |
Thomas J. Ouellette | M | - | 16 years | |
Penny M. Heaton | M | 59 | 7 years | |
Zofia E. Dziewanowska | M | 82 | - | |
Gary T. Shearman | M | - | 5 years | |
Timothy Walbert | M | 57 | 1 years | |
Samuel O. Thier | M | 86 | 16 years | |
Larry Bossidy | M | 89 | 14 years | |
Heidi Miller | M | 70 | 4 years | |
Philippe Schaison | M | 62 | 7 years | |
Tassos Gianakakos | M | 51 | 2 years | |
Timothy Proctor | M | 74 | 13 years | |
Nolan Sigal | M | 73 | 10 years | |
Abraham E. Cohen | M | 87 | 10 years | |
David Arkowitz | M | 62 | 3 years | |
Simon Benito | M | 79 | 25 years | |
Wendy Dixon | M | 68 | 5 years | |
Paul Howes | M | 69 | 5 years | |
Celia A. Colbert | F | 67 | - | |
Beth Seidenberg | M | 67 | 2 years | |
Erskine B. Bowles | M | 78 | 2 years | |
Michael Tarnow | M | 79 | 22 years | |
Bernard J. Kelley | M | 82 | 10 years | |
Gregory S. Patrick | M | 72 | 14 years | |
Gerald J. Gallivan | M | - | - | |
Horace D. Nalle | M | - | - | |
Ian M. Miller | M | - | 11 years | |
Roger Perlmutter | M | 71 | 4 years | |
Susan Molineaux | M | 70 | 5 years | |
Douglas J. MacMaster | M | 93 | 31 years | |
John W. Gillard | M | - | 11 years | |
Jerome C. Keller | M | 81 | 7 years | |
Alan Nies | M | 86 | 10 years | |
George Morrow | M | 72 | 11 years | |
David S. Doll | M | - | 8 years | |
Jeffrey A. Peris | M | 77 | 25 years | |
Vijay Samant | M | 77 | 23 years | |
Margaret McGlynn | F | 64 | 11 years | |
Stewart John Hen | M | 57 | 4 years | |
Soren Christiansen | M | 68 | 19 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronald Newbold
- Personal Network